Article
- The EMBO Journal (2000) 19, 662 - 671
- doi:10.1093/emboj/19.4.662
Regulation of E2F1 activity by acetylation
Marian A. Martínez-Balbás1,2, Uta-Maria Bauer1,2, Søren J. Nielsen1, Alexander Brehm1 and Tony Kouzarides1
- Wellcome/CRC Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK
- M.A.Martínez-Balbás and U.-M.Bauer contributed equally to this work
Correspondence to:
Tony Kouzarides, E-mail: tk106@mole.bio.cam.ac.uk
Received 9 September 1999; Accepted 9 December 1999; Revised 9 December 1999
Abstract
During the G1 phase of the cell cycle, an E2F–RB complex represses transcription, via the recruitment of histone deacetylase activity. Phosphorylation of RB at the G1/S boundary generates a pool of 'free' E2F, which then stimulates transcription of S-phase genes. Given that E2F1 activity is stimulated by p300/CBP acetylase and repressed by an RB-associated deacetylase, we asked if E2F1 was subject to modification by acetylation. We show that the p300/CBP-associated factor P/CAF, and to a lesser extent p300/CBP itself, can acetylate E2F1 in vitro and that intracellular E2F1 is acetylated. The acetylation sites lie adjacent to the E2F1 DNA-binding domain and involve lysine residues highly conserved in E2F1, 2 and 3. Acetylation by P/CAF has three functional consequences on E2F1 activity: increased DNA-binding ability, activation potential and protein half-life. These results suggest that acetylation stimulates the functions of the non-RB bound 'free' form of E2F1. Consistent with this, we find that the RB-associated histone deacetylase can deacetylate E2F1. These results identify acetylation as a novel regulatory modification that stimulates E2F1's activation functions.
Keywords:
- acetylation,
- E2F1,
- histone deacetylase,
- p300,
- P,
- CAF,
- retinoblastoma protein



